Physician profile
Roberto Chao
NPI 1811942212
$725.42
in general payments reported to CMS, 2019-2025
12 companies · $18.21 in 2025
The $18.21 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $232 · 2021: $47.50 · 2022: $70.65 · 2023: $66.28 · 2024: $164 · 2025: $18.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $233.49 | 2020-2022 | |
| Bioprotect Medical, INC. | $163.68 | 2024 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $58.23 | 2019 | |
| Pfizer INC. | $54.62 | 2019-2023 | |
| Myovant Sciences INC. | $44.77 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $41.44 | 2023 | |
| Smith+Nephew, INC. | $38.28 | 2022 | |
| Acell, INC. | $22.89 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.48 | 2019 | |
| Urovant Sciences INC | $18.26 | 2021 | |
| Angiodynamics, INC. | $18.21 | 2025 | Nanoknife |
| Amgen INC. | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Chao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.